These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 1186124

  • 1. Identification of premalignant hyperplasia in methylcholanthrene-induced mammary tumorogenesis.
    Fisher ER, Shoemaker RH, Palekar AS.
    Lab Invest; 1975 Oct; 33(4):446-50. PubMed ID: 1186124
    [Abstract] [Full Text] [Related]

  • 2. Relationship of hyperplasia to cancer in 3-methylcholanthrene-induced mammary tumorogenesis.
    Fisher ER, Shoemaker RH, Sabnis A.
    Lab Invest; 1975 Jul; 33(1):33-42. PubMed ID: 1142740
    [Abstract] [Full Text] [Related]

  • 3. Hyperplastic lesions of mouse mammary glands after treatment with 3-methylcholanthrene.
    Faulkin LJ.
    J Natl Cancer Inst; 1966 Feb; 36(2):289-97. PubMed ID: 4286277
    [No Abstract] [Full Text] [Related]

  • 4. Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats.
    Yuri T, Tsukamoto R, Uehara N, Matsuoka Y, Tsubura A.
    In Vivo; 2006 Feb; 20(6B):829-36. PubMed ID: 17203775
    [Abstract] [Full Text] [Related]

  • 5. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
    Swanson SM, Christov K.
    Anticancer Res; 2003 Feb; 23(4):3207-13. PubMed ID: 12931682
    [Abstract] [Full Text] [Related]

  • 6. [Morphology of the collateral mammae in induced mammary carcinoma in BALB/c/Cb/Se mice].
    Biancifiori C.
    Lav Ist Anat Istol Patol Univ Studi Perugia; 1977 Feb; 37(1):19-28. PubMed ID: 559894
    [No Abstract] [Full Text] [Related]

  • 7. Susceptibility of mammary-tumor-virus-free BALB-c mouse mammary nodule outgrowth cells in DNA synthesis to 3-methylcholanthrene tumorigenesis.
    Adamson R, Banerjee MR, Medina D.
    J Natl Cancer Inst; 1971 Apr; 46(4):899-907. PubMed ID: 5573774
    [No Abstract] [Full Text] [Related]

  • 8. Chemoprevention of N-nitroso-N-methylurea-induced mammary cancers by pretreatment with 17 beta-estradiol and progesterone.
    Grubbs CJ, Farnell DR, Hill DL, McDonough KC.
    J Natl Cancer Inst; 1985 Apr; 74(4):927-31. PubMed ID: 3857386
    [Abstract] [Full Text] [Related]

  • 9. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
    Ting AY, Kimler BF, Fabian CJ, Petroff BK.
    Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
    [Abstract] [Full Text] [Related]

  • 10. Lack of antigenicity of mammary tumors induced by carcinogens in a nonantigenic preneoplastic lesion.
    Halpin ZT, Vaage J, Blair PB.
    Cancer Res; 1972 Oct; 32(10):2197-200. PubMed ID: 5080764
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 4-(hydroxyphenyl)retinamide selectively inhibits the development and progression of ductal hyperplastic lesions and carcinoma in situ in mammary gland.
    Green A, Shilkaitis A, Christov K.
    Carcinogenesis; 1999 Aug; 20(8):1535-40. PubMed ID: 10426803
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. N-methyl-N-nitrosourea-induced mammary carcinogenesis is promoted by short-term treatment with estrogen and progesterone mimicking pregnancy in aged female Lewis rats.
    Tsukamoto R, Mikami T, Miki K, Uehara N, Yuri T, Matsuoka Y, Okazaki K, Tsubura A.
    Oncol Rep; 2007 Aug; 18(2):337-42. PubMed ID: 17611653
    [Abstract] [Full Text] [Related]

  • 16. Classification of premalignant and malignant lesions developing in the rat mammary gland after injection of sexually immature rats with 1-methyl-1-nitrosourea.
    Thompson HJ, Singh M, McGinley J.
    J Mammary Gland Biol Neoplasia; 2000 Apr; 5(2):201-10. PubMed ID: 11149573
    [Abstract] [Full Text] [Related]

  • 17. Synergistic effects of androgen and estrogen on the mouse uterus and mammary gland.
    Zhang J, Sun Y, Liu Y, Sun Y, Liao DJ.
    Oncol Rep; 2004 Oct; 12(4):709-16. PubMed ID: 15375489
    [Abstract] [Full Text] [Related]

  • 18. Hormone dependent and independent mammary tumor development form N-methyl-N-nitrosourea-treated rat mammary epithelial cell xenografts in the nude mouse: multiple pathways and H-ras activation.
    Hwang SI, Guzman RC, Swanson SM, Nandi S.
    Cancer Lett; 1996 Mar 19; 101(1):123-34. PubMed ID: 8625275
    [Abstract] [Full Text] [Related]

  • 19. Effects of exposure of neonatal mice to 17beta-estradiol on subsequent age-incidence and morphology of carcinogen-induced mammary dysplasia.
    Warner MR, Warner RL.
    J Natl Cancer Inst; 1975 Aug 19; 55(2):289-98. PubMed ID: 808639
    [Abstract] [Full Text] [Related]

  • 20. Rat strain-specific actions of 17beta-estradiol in the mammary gland: correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers.
    Harvell DM, Strecker TE, Tochacek M, Xie B, Pennington KL, McComb RD, Roy SK, Shull JD.
    Proc Natl Acad Sci U S A; 2000 Mar 14; 97(6):2779-84. PubMed ID: 10688907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.